White&Trust Pharmaceuticals (India) Private Limited - Company Profile

It is a pharma private limited company based in Nagpur, Maharashtra, India, established in 2012.
2012 Nagpur, Maharashtra, India Active
Last Updated:
Access Report
About White&Trust Pharmaceuticals (India) Private Limited

White&Trust Pharmaceuticals (India) Private Limited, a active private limited company, was established on 05 July 2012 in Nagpur, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24230MH2012PTC233018. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.38 M.

It upholds a compliant status. Employing 51 professional, Its leadership includes Sameer Ashokrao Bhalerao (Director), Girish Deorao Lad (Director), Vrushali Sameer Bhalerao (Director). Past directors included Girish Deorao Lad, Shailesh Vilasrao Dhabekar. It holds ₹12.15 Cr open charges and ₹7.06 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at C/O Vilas R Dhabekar, Sharda Chowk, Jalalpura, Near Patel Roadways,Gandhibag,, Nagpur, Maharashtra, 440002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH2012PTC233018

  • Registration Number

    233018

  • Incorporation Date

    05 July 2012

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.38 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.38 M
  • Company Age 13 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 12.15 Cr
  • Satisfied Charges ₹ 7.06 M
  • Revenue Growth **** 25.88%
  • Profit Growth **** 19.99%
  • Ebitda **** 49.36%
  • Net Worth 19.32%
  • Total Assets **** 25.86%
Company report

White&Trust Pharmaceuticals (India) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into White&Trust Pharmaceuticals (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at White&Trust Pharmaceuticals (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Sameer Ashokrao Bhalerao Director 05 Jul 2012 Current
Girish Deorao Lad Director 05 Feb 2022 Current
Vrushali Sameer Bhalerao Director 29 Sep 2017 Current
Shailesh Vilasrao Dhabekar Director 05 Feb 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 Mar 2019 Past
Pramod Abcsdd Director 30 Mar 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of White&Trust Pharmaceuticals (India).

White&Trust Pharmaceuticals (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.88% increase. The company also saw a substantial improvement in profitability, with a 19.99% increase in profit. The company's net worth Soared by an impressive increase of 19.32%.

White&Trust Pharmaceuticals (India) revenue growth over time
White&Trust Pharmaceuticals (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 25.88%
*******
*******
*******
*******
Revenue from Operations
*******
 25.89%
*******
*******
*******
*******
Total Assets
*******
 25.86%
*******
*******
*******
*******
Profit or Loss
*******
 19.99%
*******
*******
*******
*******
Net Worth
*******
 19.32%
*******
*******
*******
*******
EBITDA
*******
 49.36%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of White&Trust Pharmaceuticals (India)?

Unlock access to White&Trust Pharmaceuticals (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹121,500,000.00

Satisfied Charges

₹7,060,000.00

Charges Breakdown by Lending Institutions
  • Others : 12.15 Cr
Latest Charge Details
Date Lender Amount Status
11 Oct 2024 Others ₹5.95 Cr Open
01 Feb 2023 Others ₹5.00 Cr Open
20 Jan 2021 Others ₹1.20 Cr Open
09 Oct 2014 Uco Bank ₹7.06 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at White&Trust Pharmaceuticals (India)?

White&Trust Pharmaceuticals (India) has a workforce of 51 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of White&Trust Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped White&Trust Pharmaceuticals (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on White&Trust Pharmaceuticals (India)
Recent Activity within the Organization
  • Annual General Meeting

    Progress on White&Trust Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity White&Trust Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 59.50 M with Charge ID 101006958 was registered on 11 Oct 2024. was documented.

  • Charges

    A charge with Others of Rs. 12.00 M registered on 20 Jan 2021 with Charge ID 100414451 was modified on 20 Mar 2023. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 50.00 M with Charge ID 100678983 was registered on 01 Feb 2023. was completed.

  • Charges

    The activity A charge with Others of Rs. 50.00 M registered on 01 Feb 2023 with Charge ID 100678983 was modified on 01 Feb 2023. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of White&Trust Pharmaceuticals (India) Private Limited?

The CIN of White&Trust Pharmaceuticals (India) Private Limited is U24230MH2012PTC233018.

Where is White&Trust Pharmaceuticals (India) Private Limited headquartered?

White&Trust Pharmaceuticals (India) Private Limited is headquartered at C/O Vilas R Dhabekar, Sharda Chowk, Jalalpura, Near Patel Roadways,Gandhibag,, Nagpur, Maharashtra, 440002.

When was White&Trust Pharmaceuticals (India) Private Limited incorporated?

White&Trust Pharmaceuticals (India) Private Limited was incorporated on 05 July 2012.

Who are the current directors of White&Trust Pharmaceuticals (India) Private Limited?

The current directors of White&Trust Pharmaceuticals (India) Private Limited are

What is the primary industry of White&Trust Pharmaceuticals (India) Private Limited?

The primary industry of White&Trust Pharmaceuticals (India) Private Limited is Manufacturing.

Is White&Trust Pharmaceuticals (India) Private Limited a listed company?

White&Trust Pharmaceuticals (India) Private Limited is unlisted.

What is the capital structure of White&Trust Pharmaceuticals (India) Private Limited?

The authorized capital of White&Trust Pharmaceuticals (India) Private Limited is ₹1.00 M, and the paid-up capital is ₹0.38 M.

What is the compliance status of White&Trust Pharmaceuticals (India) Private Limited?

The compliance status of White&Trust Pharmaceuticals (India) Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available